Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1

Molecular Cell

Volumn 12, Issue 2, 2003, Pages 393-400

  Smith, Kevin S ^a   Chanda, Sumit K ^a   Lingbeek, Merel ^b   Ross, Douglas T ^a   Botstein, David ^a   Van Lohuizen, Maarten ^b   Cleary, Michael L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; ONCOPROTEIN; ONCOPROTEIN E2A PBX1; PROTEIN P16; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; ONCOGENE BMI 1; PRE B LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0141922983     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00277-6     Document Type: Article

References (50)

1. Alcorta D.A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J.C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA. 93:1996;13742-13747.
2. Asahara H., Dutta S., Kao H.Y., Evans R.M., Montminy M. Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner. Mol. Cell. Biol. 19:1999;8219-8225.
3. Carnero A., Hudson J.D., Price C.M., Beach D.H. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat. Cell Biol. 2:2000;148-155.
4. Chang C.-P., Shen W.-F., Rozenfeld S., Lawrence H.J., Largman C., Cleary M.L. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev. 9:1995;663-674.
5. Chin L., Pomerantz J., DePinho R.A. The INK4a/ARF tumor suppressor. one gene-two products-two pathways Trends Biochem. Sci. 8:1998;291-296.
6. Cohen K.J., Hanna J.S., Prescott J.E., Dang C.V. Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity. Mol. Cell. Biol. 16:1996;5527-5535.
7. Dedera D.A., Waller E.K., LeBrun D.P., Sen-Majumdar A., Stevens M.E., Barsh G.S., Cleary M.L. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell. 74:1993;833-843.
8. DeRisi J.L., Iyer V.R., Brown P.O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science. 278:1997;680-686.
9. DiMartino J.F., Selleri L., Traver D., Firpo M.T., Rhee J., Warnke R., O'Gorman S., Weissman I.L., Cleary M.L. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood. 98:2001;618-626.
10. Drexler H.G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 12:1998;845-859.
11. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA. 95:1998;14863-14868.
12. Fu X., Kamps M.P. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol. Cell. Biol. 17:1997;1503-1512.
13. Haber D.A. Splicing into senescence. the curious case of p16 and p19ARF Cell. 91:1997;555-558.
14. Haupt Y., Alexander W.S., Barri G., Klinken S.P., Adams J.M. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice. Cell. 65:1991;753-763.
15. Hunger S.P., Ohyashiki K., Toyama K., Cleary M.L. Hlf, a novel hepatic bZIP protein, shows altered DNA binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev. 6:1992;1608-1620.
16. Iyer V.R., Eisen M.B., Ross D.T., Schuler G., Moore T., Lee J.C.F., Trent J.M., Staudt L.M., Hudson J. Jr., Boguski M.S.et al. The transcriptional program in the response of human fibroblasts to serum. Science. 283:1999;83-87.
17. Jacobs J.J.L., Kieboom K., Marino S., DePinho R.A., van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:1999;164-168. a.
18. Jacobs J.J.L., Scheijen B., Voncken J.-W., Kieboom K., Berns A., van Lohuizen J. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13:1999;2678-2690. b.
19. Kamps M.P., Wright D.D. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene. 11:1994;3159-3166.
20. Kamps M.P., Murre C.M., Sun X.-H., Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 60:1990;547-555.
21. Kim S.K., Selleri L., Lee J.S., Zhang A.Y., Gu X., Jacobs Y., Cleary M.L. Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nat. Genet. 30:2002;430-435.
22. Kinsell T.M., Nolan G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1996;1405-1413.
23. Lavau C., Szilvassy S.J., Slany R., Cleary M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16:1997;4226-4237.
24. LeBrun D.P., Cleary M.L. Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias. Oncogene. 9:1994;1641-1647.
25. Lessard J., Baban S., Sauvageau G. Stage-specific expression of Polycomb Group genes in human bone marrow cells. Blood. 91:1998;1216-1224.
26. Lu Q., Wright D.D., Kamps M.P. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol. Cell. Biol. 14:1994;3938-3948.
27. INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations. Leukemia. 12:1998;1417-1421.
28. Mann R., Affolter M. Hox proteins meet more partners. Curr. Opin. Genet. Dev. 8:1998;423-429.
29. Mann R.S., Chan S.-K. Extra specificity from extradenticle. the partnership between HOX and PBX/EXD homeodomain proteins Trends Genet. 12:1996;258-262.
30. McWhirter J.R., Goulding M., Weiner J.A., Chun J., Murre C. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development. 124:1997;3221-3232.
31. McWhirter J.R., Neuteboom S.T., Wancewicz E.V., Monia B.P., Downing J.R., Murre C. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc. Natl. Acad. Sci. USA. 96:1999;11464-11469.
32. Monica K., LeBrun D.P., Dedera D.A., Brown R., Cleary M.L. Transformation properties of the E2a-Pbx1 chimeric oncoprotein. fusion with E2a is essential but the Pbx1 homeodomain is dispensible Mol. Cell. Biol. 14:1994;8304-8313.
33. Noble J.R., Rogan E.M., Neumann A.A., Maclean K., Bryan T.M., Reddel R.R. Association of extended in vitro proliferative potential with loss of p16INK4 expression. Oncogene. 13:1996;1259-1268.
34. Nourse J., Mellentin J.D., Galili N., Wilkinson J., Stanbridge E., Smith S.D., Cleary M.L. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell. 60:1990;535-546.
35. Ohnishi H., Hanada R., Horibe K., Hongo T., Kawamura M., Naritaka S., Bessho F., Yanagisawa M., Nobori T., Yamamori S.et al. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood. Leukemia. 10:1996;1104-1110.
36. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
37. Quelle D.E., Zindy F., Ashmun R.A., Sherr C.J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:1995;993-1000.
38. Quong M.W., Massari M.E., Zwart R., Murre C. A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol. Cell. Biol. 13:1993;792-800.
39. Selleri L., Depew M.J., Jacobs Y., Chanda S.K., Tsang K.Y., Cheah K.S.E., Rubenstein J.L.R., O'Gorman S., Cleary M.L. Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation. Development. 128:2001;3543-3557.
40. Serrano M., Lee H.-W., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role or the INK4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-36.
41. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
42. Sherr C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:1998;2984-2991.
43. Smith K.S., Jacobs Y., Chang C.-P., Cleary M.L. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2. Oncogene. 14:1997;2917-2926.
44. Stamenkovic I., Seed B. CD19, the earliest differentiation antigen of the Bcell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail. J. Exp. Med. 168:1988;1205-1210.
45. INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells. Blood. 90:1997;4106-4115.
46. Van Dijk M.A., Voorhoeve P.M., Murre C. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc. Natl. Acad. Sci. USA. 90:1993;6061-6065.
47. van Lohuizen M.S., Verbeek S., Schiejen B., Wientjens E., van der Gulden H., Berns A. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging. Cell. 65:1991;737-752. a.
48. van Lohuizen M., Frasch M., Wientjens E., Berns A. Sequence similarity between the mammalian Bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2. Nature. 353:1991;353-355. b.
49. Wang J., Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science. 273:1996;359-363.
50. Yee J.K., Friedmann T., Burns J.C. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43:1994;99-112.